International Journal Of Drug Regulatory Affairs
  • Year: 2022
  • Volume: 10
  • Issue: 3

Evaluation of the patentability of medicines based on plants produced in cameroon: Case of yaounde

  • Author:
  • Minyem Ngombi Afuh Aude Perine1,2,*, Ekeme Kevin1, Maniepi Saurelle1, Soppo Lobe Vanessa Charlotte1, Nyangono Ndongo Martin1, Mbole Mvondo Jeanne Mauricette1, Benga Chimene1, Nnanga Nga1
  • Total Page Count: 6
  • Page Number: 19 to 24

1Department of Galenic Pharmacy and Pharmaceutical Legislation, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Cameroon

2Directorate of Pharmacy, Drug and Laboratories, Ministry of Public Health, Cameroon

*Correspondina author

Online published on 16 November, 2022.

Abstract

Assess the patentability of medicines based on plants produced in Cameroon.

An analytical study, conducted at the Library of the Faculty of Medicine and Biomedical Sciences of the University of Yaounde I and the Directorate of Pharmacy, Drug and Laboratories (DPML) from November 2021 to June 2022. We conducted a consecutive and non-exhaustive sampling that allowed us to identify 51 drugs and evaluate 16 of them. After that, we proceeded to assess the patentability of our samples exclusively on the criteria of novelty, inventive ability and industrial application.

With regard to patentability, we obtained a patentability percentage of 75%, which shows that the potential for innovation in traditional medicine is enormous.

Cameroon has a rich plant heritage with high therapeutic potential, which it is important to develop. The patent, provides researchers guaranteed and solutions for the protection and enhancement of their inventions.

Keywords

Patents, Intellectual Property, Directorate of Pharmacy, Drug and Laboratories (DPML), WHO, WIPO